Knockdown of CDK8 inhibited tumor growth and prolonged the survival of intracranial tumor-bearing mice relative to shNull, reinforcing CDK8 as a crucial factor controlling the growth of MYC-amplified MB (Fig. 1m,n and Fig. S1e). Here, CDK8 is linked to neoplasm.